2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs
Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,350. The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.
2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is Venture Planning Group’s new study of the major business opportunities emerging in the Italian cancer diagnostics market during the nextfive years. The report examines trends in the Italian market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.
Rationale
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Italian cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.
Italian Market Overview
Analysis of major molecular diagnostic and immunodignostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.
Technology Assessment
Strategic assessments ofmajor suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.
The companies analyzed in the report include:
2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is Venture Planning Group’s new study of the major business opportunities emerging in the Italian cancer diagnostics market during the nextfive years. The report examines trends in the Italian market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.
Rationale
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Italian cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.
Italian Market Overview
- Five-year test volume and sales projections.
- Comprehensive Market Segmentation Analysis, including review of the market dynamics, structure, size, growth and major suppliers.
- Estimated universe of laboratories performing cancer diagnostic testing.
- Cancer statistics, etiology and recent developments in Italy.
- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Oncogenes
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Hormones
- Immunohistochemical Stains
- Lymphokines
- Sales and market shares of major cancer diagnostic product suppliers by individual test.
- Five-year test volume and sales forecasts for major tumor markers by market segment, including:
- Hospitals
- Commercial/Private Laboratories
Analysis of major molecular diagnostic and immunodignostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.
Technology Assessment
- Assessment of latest technologies and their potential applications for cancer diagnostic testing.
- Review of competing/complementing technologies.
- Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.
Strategic assessments ofmajor suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.
The companies analyzed in the report include:
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca/Nuvelo
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode
- Diadexus
- Diagnocure
- DiaSorin
- Eiken Chemical
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio/Innogenetics
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- Nanogen Elitech
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen/Ipsogen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher/Life Technologies
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zilla
I. Introduction
II. Worldwide Market Overview
A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth
III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Market and Technology Overview
A. Major Current and Emerging Cancer Diagnostic Tests
1. BIOCHEMICAL TUMOR MARKERS
2. ONCOGENES
3. POLYPEPTIDE GROWTH FACTORS
4. ECTOPIC HORMONES
5. COLONY STIMULATING FACTORS
6. LYMPHOKINES
7. IMMUNOHISTOCHEMICAL STAINS
8. EMERGING TUMOR MARKERSTABLE OF CONTENTS
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing
VIII. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
IX. Competitive Profiles
Abbott
AdnaGen
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode
Diadexus
Diagnocure
Diasorin
Eiken ChemicalTable of Contents
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio/Innogenetics
Guided Therapeutics
Hologic/Gen-Probe
Kreatech
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
Nanogen Elitech
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen/Ipsogen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher/Life Technologies
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila
X. Appendix: Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications
List of Tables
Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table:
Italy, Total Cancer Diagnostic Testing Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Estimated Cancer Death Rates
Italy, Laboratories Performing Cancer Diagnostic Tests by Market Segment
Italy, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
Italy, Commercial/Private Laboratories Performing Cancer Diagnostics Tests by Annual Test Volume
Italy, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
Italy, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts
Italy, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
Italy, Total Cancer Diagnostic Test Market Forecasts by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
Italy, Hospital Laboratories Major Cancer Diagnostic Forecasts by Test
Italy, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Italy, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CA-19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CA 125 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Chromogranin Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
Italy, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, S-100 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Total Cancer Diagnostics Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics Sales by Major Supplier
Italy, CEA Testing Market Diagnostics Sales by Major Supplier
Italy, PSA Testing Market Diagnostics Sales by Major Supplier
II. Worldwide Market Overview
A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth
III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Market and Technology Overview
A. Major Current and Emerging Cancer Diagnostic Tests
1. BIOCHEMICAL TUMOR MARKERS
2. ONCOGENES
3. POLYPEPTIDE GROWTH FACTORS
4. ECTOPIC HORMONES
5. COLONY STIMULATING FACTORS
6. LYMPHOKINES
7. IMMUNOHISTOCHEMICAL STAINS
8. EMERGING TUMOR MARKERSTABLE OF CONTENTS
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing
VIII. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
Volume Forecasts by Test and Market Segment
Sales Forecasts by Test and Market Segment
Major Supplier Sales and Market Shares
IX. Competitive Profiles
Abbott
AdnaGen
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode
Diadexus
Diagnocure
Diasorin
Eiken ChemicalTable of Contents
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio/Innogenetics
Guided Therapeutics
Hologic/Gen-Probe
Kreatech
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
Nanogen Elitech
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen/Ipsogen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher/Life Technologies
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila
X. Appendix: Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications
List of Tables
Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table:
Italy, Total Cancer Diagnostic Testing Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Estimated Cancer Death Rates
Italy, Laboratories Performing Cancer Diagnostic Tests by Market Segment
Italy, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
Italy, Commercial/Private Laboratories Performing Cancer Diagnostics Tests by Annual Test Volume
Italy, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
Italy, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts
Italy, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
Italy, Total Cancer Diagnostic Test Market Forecasts by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
Italy, Hospital Laboratories Major Cancer Diagnostic Forecasts by Test
Italy, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Italy, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CA-19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CA 125 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Chromogranin Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
Italy, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, S-100 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Total Cancer Diagnostics Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics Sales by Major Supplier
Italy, CEA Testing Market Diagnostics Sales by Major Supplier
Italy, PSA Testing Market Diagnostics Sales by Major Supplier
